A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
November 30th, 2021
3.8K views
Necrotizing enterocolitis (NEC) is the most severe gastrointestinal (GI) disease that often occurs in premature infants, especially very low birth weight infants, with high mortality and unclear pathogenesis. The cause of NEC may be related to inflammatory immune regulatory system abnormalities. An NEC animal model is an indispensable tool for NEC disease immune research. NEC animal models usually use C57BL/6J neonatal mice; BALB/c neonatal mice are rarely used. Related studies have shown that when mice are infected, Th2
Overview
This study establishes a necrotizing enterocolitis (NEC) model using neonatal BALB/c mice, which may enhance understanding of T cell responses in NEC. The model mimics clinical characteristics and intestinal changes seen in infants with NEC.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Pediatrics
Background
- Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease in premature infants.
- NEC is associated with high mortality and unclear pathogenesis.
- Animal models are crucial for studying the immune response in NEC.
- BALB/c neonatal mice have not been widely used in NEC research.
Purpose of Study
- To establish an NEC model using neonatal BALB/c mice.
- To investigate T helper type 2 (Th2) cell responses in NEC.
- To compare the clinical characteristics of the model with those observed in infants.
Methods Used
- Induction of NEC in neonatal BALB/c mice.
- Monitoring of body size and weight changes over time.
- Assessment of survival rates during model establishment.
- Evaluation of intestinal pathological changes.
Main Results
- NEC mice showed significant weight loss compared to control mice by day 10.
- The survival rate of NEC mice decreased over the five-day model establishment period.
- The model demonstrated potential for studying T cell polarization.
- Clinical characteristics were similar to those observed in infants with NEC.
Conclusions
- The BALB/c mouse model is a valuable tool for NEC research.
- Further studies are needed to explore Th2 cell responses in NEC.
- This model may help in understanding the immune mechanisms involved in NEC.
Frequently Asked Questions
What is necrotizing enterocolitis (NEC)?
NEC is a severe gastrointestinal disease that primarily affects premature infants, leading to high mortality rates.
Why are animal models important for NEC research?
Animal models help researchers understand the immune responses and pathogenesis of NEC, which is crucial for developing treatments.
What are Th2 cells?
Th2 cells are a type of T helper cell involved in the immune response, particularly in allergic reactions and responses to parasitic infections.
How does the BALB/c mouse model compare to other models?
The BALB/c mouse model may provide unique insights into Th2 cell responses, which are less studied compared to other strains like C57BL/6J.
What were the main findings of this study?
The study found that NEC mice had significant weight loss and decreased survival rates, indicating the model's relevance for studying NEC.
What future research is suggested?
Further research is needed to investigate the immune mechanisms, particularly Th2 cell responses, in the context of NEC.
Executive Industry Relevance
Establishing a neonatal BALB/c mouse model of necrotizing enterocolitis (NEC) provides a disease-relevant system for studying immune mechanisms, particularly T helper type 2 (Th2) cell polarization, in a preclinical setting. This model supports mechanistic de-risking by enabling hypothesis testing of immune-mediated pathways in NEC pathogenesis. It offers translational continuity from discovery to preclinical validation, aiding in target validation and predictive confidence for immunomodulatory interventions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses linking Th2 cell responses to NEC disease progression.
- Operational Value: Provides a reproducible system for functional target validation of immune regulators in NEC.
- Scientific Value: Supports biological de-risking by modeling immune dysregulation observed in premature infants.
Screening & Assay Development
- Scientific Value: Generates quantitative histopathological and clinical readouts (e.g., intestinal pathology score, stool consistency, weight loss) for assay standardization.
- Operational Value: Delivers measurable endpoints to assess compound effects on intestinal integrity and immune activation.
- Scientific Value: Facilitates screening readiness through standardized induction protocols involving LPS, formula feeding, hypoxia, and cold stress.
Translational & Preclinical Research
- Scientific Value: Mirrors clinical NEC features such as intestinal necrosis, hemorrhage, and Th2-skewed immunity in BALB/c mice.
- Operational Value: Enables longitudinal monitoring of survival, weight, and histopathological changes for risk-adjusted advancement decisions.
- Scientific Value: Supports predictive confidence by aligning model outcomes with infant NEC phenotypes.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation to preclinical evaluation, particularly for immunomodulatory candidates targeting Th2-mediated pathways in NEC.
- Discovery Biology: Tests hypotheses about T cell polarization and immune imbalance in NEC pathogenesis.
- Screening: Delivers reproducible quantitative outputs (pathology scoring, survival, weight) for compound evaluation.
- Analytics: Provides histopathological and clinical metrics to compare experimental conditions and assess mechanistic effects.
- Translational Research: Connects immune findings in mice to human NEC through shared clinical and pathological features.
- Enterprise Reuse: Serves as a reusable platform for studying immune modulators and biomarkers in NEC.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by modeling Th2-associated immune responses.
- Operational Value: Ensures standardization through defined induction and monitoring procedures.
- Strategic Value: Improves go/no-go decisions by reducing mechanistic ambiguity in immune-mediated NEC.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on immune modulation efficacy.
Implementation Considerations
- Requires expertise in neonatal mouse handling, gavage, and hypoxia exposure.
- Depends on access to hypoxia chambers, incubators, and histology equipment for tissue processing.
- Necessitates standardized scoring systems for intestinal pathology and stool consistency across teams.
- Involves adaptation considerations when translating findings to other mouse strains or human systems.
- Limited by the model’s focus on acute immune responses rather than long-term developmental outcomes.
Biopharma FAQs
Why does histopathological scoring matter for target validation in NEC models?
Histopathological scoring quantifies intestinal tissue damage, such as submucosal separation and villi loss, providing an objective measure to evaluate the severity of NEC and the impact of experimental interventions on intestinal integrity.
How does isolating independent variables like hypoxia and LPS exposure support discovery pipeline integrity?
Controlling variables such as hypoxia duration, LPS dosage, and feeding schedule ensures reproducible model induction, which is essential for reliable target validation and comparative analysis across experimental groups.
What quantitative dependent variable measurements enable mechanistic de-risking in NEC research?
Dependent variables including weight loss, survival rate, stool consistency, and intestinal pathology scores provide quantifiable endpoints to assess disease progression and immune-mediated effects, supporting hypothesis testing and target validation.
Why do replication requirements matter for cross-functional collaboration in NEC model studies?
Replication across litters and experimental runs ensures model consistency and data reliability, which is critical for aligning discovery, preclinical, and translational teams on target validation and safety assessments.
What statistical analysis capabilities are required before implementing this NEC model in discovery workflows?
The model requires statistical comparison of outcomes such as pathology scores and survival rates between NEC and control groups, as demonstrated by significant differences with p < 0.001, to validate experimental effects and support data-driven decisions.
Chapters in this video
0:04
Introduciton
1:02
Induction of Necrotizing Enterocolitis Model
1:45
Mouse Gavage
2:22
Collection of Intestinal Tissue for Hematoxylin and Eosin (H&E) Staining
3:13
Results: Necrotizing Enterocolitis (NEC) Mouse Model and Associated Pathology
4:44
Conclusion
